Jove
Visualize
Contáctanos

Videos de Conceptos Relacionados

Allergic Reactions02:06

Allergic Reactions

27.4K
Overview
27.4K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

396
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
396
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
Asthma-I: Introduction01:29

Asthma-I: Introduction

2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

442
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
442
Drugs Used in Upper Respiratory Disorders: Overview01:16

Drugs Used in Upper Respiratory Disorders: Overview

247
Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
247

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

A concept for integrated care pathways for atopic dermatitis-A GA<sup>2</sup> LEN ADCARE initiative.

Clinical and translational allergy·2023
Same author

Evaluation of patient-reported outcome measures for on-demand treatment of hereditary angioedema attacks and design of KONFIDENT, a phase 3 trial of sebetralstat.

Clinical and translational allergy·2023
Same author

Clinical severity classes in COVID-19 pneumonia have distinct immunological profiles, facilitating risk stratification by machine learning.

Frontiers in immunology·2023
Same author

Efficacy of Biologics in Patients with Allergic Severe Asthma, Overall and by Blood Eosinophil Count: A Literature Review.

Advances in therapy·2023
Same author

An updated review of pediatric autoimmune neuropsychiatric disorders associated with Streptococcus/pediatric acute-onset neuropsychiatric syndrome, also known as idiopathic autoimmune encephalitis: What the allergist should know.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2023
Same author

Urticaria exacerbations and adverse reactions in patients with chronic urticaria receiving COVID-19 vaccination: Results of the UCARE COVAC-CU study.

The Journal of allergy and clinical immunology·2023
Same journal

Specialized or General-Purpose-The Wrong Question for Mental Health AI Safety.

JAMA·2026
Same journal

Pricing for Oncology Biosimilars.

JAMA·2026
Same journal

Familial Hypercholesterolemia.

JAMA·2026
Same journal

Reporting Error.

JAMA·2026
Same journal

Replacement Text for Funding/Support Section.

JAMA·2026
Same journal

Pricing for Oncology Biosimilars-Reply.

JAMA·2026
Ver todos los artículos relacionados
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Video Experimental Relacionado

Updated: Jul 1, 2025

Author Spotlight: Advancing Allergic Rhinitis Research with Multicolor Immunofluorescence
06:08

Author Spotlight: Advancing Allergic Rhinitis Research with Multicolor Immunofluorescence

Published on: September 22, 2023

1.7K

Una revisión de la rinitis alérgica

Jonathan A Bernstein1, Joshua S Bernstein1, Richika Makol2

  • 1Division of Rheumatology, Allergy, and Immunology, Department of Internal Medicine, College of Medicine, University of Cincinnati, Cincinnati, Ohio.

JAMA
|March 12, 2024
PubMed
Resumen
Este resumen es generado por máquina.

La rinitis alérgica, que afecta al 15% de la población estadounidense, implica inflamación nasal y síntomas como congestión y estornudos. Las opciones de tratamiento incluyen antihistamínicos y corticosteroides intranasales, elegidos en función de la gravedad de los síntomas y la preferencia del paciente.

Más Videos Relacionados

Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis
03:40

Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis

Published on: December 20, 2024

464
Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber
08:47

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber

Published on: March 3, 2023

2.4K

Videos de Experimentos Relacionados

Last Updated: Jul 1, 2025

Author Spotlight: Advancing Allergic Rhinitis Research with Multicolor Immunofluorescence
06:08

Author Spotlight: Advancing Allergic Rhinitis Research with Multicolor Immunofluorescence

Published on: September 22, 2023

1.7K
Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis
03:40

Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis

Published on: December 20, 2024

464
Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber
08:47

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber

Published on: March 3, 2023

2.4K

Área de la Ciencia:

  • Alergia e inmunología
  • Otorrinolaringología

Sus antecedentes:

  • La rinitis alérgica afecta al 15% de la población de los Estados Unidos, a menudo ocurre junto con el asma, el eccema y la sinusitis.
  • Surge de la penetración del alérgeno en la barrera epitelial nasal, desencadenando una respuesta inflamatoria T-helper tipo 2 y la producción de IgE.

Objetivo del estudio:

  • Describir la fisiopatología, la presentación clínica y el tratamiento de la rinitis alérgica.
  • Diferenciar la rinitis alérgica de la no alérgica sobre la base de hallazgos clínicos y pruebas de diagnóstico.
  • Proporcionar recomendaciones de tratamiento basadas en la evidencia para diversas severidades de la rinitis alérgica.

Principales métodos:

  • Revisión de la literatura existente sobre la rinitis alérgica y no alérgica.
  • Análisis de la prevalencia de los síntomas y resultados del examen físico.
  • Evaluación de las directrices terapéuticas actuales y las opciones de tratamiento.

Principales resultados:

  • La rinitis alérgica se caracteriza por respuestas IgE específicas y hallazgos físicos distintos (turbinados pálidos y edematosos).
  • La rinitis no alérgica presenta síntomas similares pero carece de IgE específico y responde menos a los corticosteroides.
  • La rinitis alérgica intermitente y persistente se define por la frecuencia y duración de los síntomas.

Conclusiones:

  • Los tratamientos de primera línea para la rinitis alérgica leve incluyen antihistamínicos H1 de segunda generación o antihistamínicos intranasales.
  • La rinitis alérgica persistente moderada a grave requiere un tratamiento inicial con corticosteroides intranasales, solos o combinados con antihistamínicos intranasales.
  • El tratamiento de la rinitis no alérgica comienza con antihistamínicos intranasales, posiblemente combinados con corticosteroides intranasales.